Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

180
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
180
Tonsillitis II: Management01:26

Tonsillitis II: Management

154
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
154
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

226
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
226
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

13
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

338
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
338
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

204
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
204

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of a Provincial Law to Improve Epinephrine Use for Anaphylaxis in Schools in Alberta, Canada: A Pre-Post Study.

International archives of allergy and immunology·2026
Same author

Delayed Consent for Research During the Emergent Care of Febrile Young Infants: Feasible, Acceptable, Doable.

Pediatric emergency care·2026
Same author

Advanced therapy in familial hypercholesterolemia.

Canadian family physician Medecin de famille canadien·2026
Same author

Healthcare costs and resource utilization for acute respiratory syncytial virus pediatric hospitalizations in Canada: a population-based study.

Lancet regional health. Americas·2025
Same author

Prophylactic salbutamol use for pediatric exercise-induced bronchoconstriction.

Canadian family physician Medecin de famille canadien·2025
Same author

Canadian family physician Medecin de famille canadien·2025

Related Experiment Video

Updated: Aug 9, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.5K

Corticosteroids for infectious mononucleosis.

Kyle Gomes, Ran D Goldman

    Canadian Family Physician Medecin De Famille Canadien
    |February 22, 2023
    PubMed
    Summary
    This summary is machine-generated.

    Corticosteroids offer minimal and inconsistent benefits for children with infectious mononucleosis (IM) symptoms. These medications should not be routinely used for common IM signs, reserving them for severe cases.

    More Related Videos

    Isolation of Tonsillar Mononuclear Cells to Study Ex Vivo Innate Immune Responses in a Human Mucosal Lymphoid Tissue
    07:38

    Isolation of Tonsillar Mononuclear Cells to Study Ex Vivo Innate Immune Responses in a Human Mucosal Lymphoid Tissue

    Published on: June 14, 2020

    7.6K
    Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
    09:57

    Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

    Published on: February 14, 2011

    12.0K

    Related Experiment Videos

    Last Updated: Aug 9, 2025

    Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
    08:44

    Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

    Published on: September 7, 2022

    2.5K
    Isolation of Tonsillar Mononuclear Cells to Study Ex Vivo Innate Immune Responses in a Human Mucosal Lymphoid Tissue
    07:38

    Isolation of Tonsillar Mononuclear Cells to Study Ex Vivo Innate Immune Responses in a Human Mucosal Lymphoid Tissue

    Published on: June 14, 2020

    7.6K
    Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
    09:57

    Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

    Published on: February 14, 2011

    12.0K

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Pharmacology

    Background:

    • Infectious mononucleosis (IM) is a prevalent viral illness frequently encountered in family medicine.
    • Key symptoms include fatigue, fever, pharyngitis, and lymphadenopathy, leading to prolonged illness and school absenteeism.
    • Effective treatments to shorten symptom duration are sought for pediatric IM patients.

    Purpose of the Study:

    • To evaluate the efficacy of corticosteroid treatment in alleviating symptoms and shortening the duration of infectious mononucleosis in children.

    Main Methods:

    • This study reviews current evidence regarding corticosteroid use in pediatric infectious mononucleosis.
    • Analysis focuses on symptom relief and overall treatment benefit.

    Main Results:

    • Current evidence indicates only small and inconsistent benefits from corticosteroid use for symptom relief in children with IM.
    • Combined corticosteroid and antiviral therapy also showed limited efficacy for common IM symptoms.

    Conclusions:

    • Corticosteroids should not be routinely administered to children for the common symptoms of infectious mononucleosis.
    • Corticosteroid use should be reserved for specific severe circumstances, such as impending airway obstruction or autoimmune complications.